← Leaderboards
Byron L Lam
University Of Miami School Of Medicine
$1,733,412
Attributed
$3,466,820
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2020–23$2M$1.5M$1M$500K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$3,466,820 · 2
By mechanism
R24$3,466,817 · 1
UG1$3 · 1
Top collaborators
- Vittorio Porciatti4 shared
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- William Jack Feuer$858,870
- Abigail Shoshana Hackam$5,813,892
- Scott W Cousins$6,323,723
- Vittorio Porciatti$11,502,425
- Carlos Torres Moraes$23,681,039
Research focus
Leber&AposGanglion CellAffectEffective TherapyFda ApprovedFundingClinical Trials DesignClinical TrialsCodon NucleotidesComplexAnimal ModelAxonBilateralAdverse EffectsFamilyChronicAcuteBlindnessArginineAmino AcidsCategoriesAtp Synthesis PathwayCellsGenes
Grant awards (7)
Mito-Targeted AAV to treat Leber Hereditary Optic Neuropathy caused by ND4 mutations$1
R24 · FY2023 · EY
Mito-Targeted AAV to treat Leber Hereditary Optic Neuropathy caused by ND4 mutations$1,061,273
R24 · FY2022 · EY
Lebers Hereditary Optic Neuropathy: Gene Therapy$1
UG1 · FY2022 · EY · contact PI
Mito-Targeted AAV to treat Leber Hereditary Optic Neuropathy caused by ND4 mutations$1,509,194
R24 · FY2021 · EY
Lebers Hereditary Optic Neuropathy: Gene Therapy$1
UG1 · FY2021 · EY · contact PI
Mito-Targeted AAV to treat Leber Hereditary Optic Neuropathy caused by ND4 mutations$896,349
R24 · FY2020 · EY
Lebers Hereditary Optic Neuropathy: Gene Therapy$1
UG1 · FY2020 · EY · contact PI